ZOLL Medical up on Q4 profit beat
ZOLL Medical Corp. (Nasdaq: ZOLL) shares are rising after the medical technology company’s fourth-quarter profit rose 26% to $6.8 million, or $0.33 per share, beating analyst estimates of $0.31 per share and compared with $5.4 million, or $0.27 per share, a year earlier.
Fourth-quarter revenue rose 25% to $74.1 million, below Wall Street projections of $85.2 million and from $59.2 million during the year-ago quarter.
“We completed a very strong fiscal year 2007 with an outstanding fourth quarter. Sales growth exceeded 25% in every part of our business, except for the military,” CEO Richard Packer said in a statement. “Success was achieved throughout the world, with International sales continuing to exceed expectations.”
In afternoon trading, ZOLL shares are up 6.12%, or $1.41, at $24.46. Over the last 52 weeks, shares have ranged from $19.91 to $37.76.
